Water → 2-[4-Chloro-5-phenyl-3-(trifluoromethyl)pyrazolo[3,4-c]pyridazin-1-yl]-1-pyrrolidin-1-yl-ethanone
Reaction equation
[H-].[Na+].[Cl:3][C:4]1[C:9]([C:10]2[CH:15]=[CH:14][CH:13]=[CH:12][CH:11]=2)=[N:8][N:7]=[C:6]2[NH:16][N:17]=[C:18]([C:19]([F:22])([F:21])[F:20])[C:5]=12.Cl[CH2:24][C:25]([N:27]1[CH2:31][CH2:30][CH2:29][CH2:28]1)=[O:26].O>CN(C=O)C.C(Cl)Cl>[Cl:3][C:4]1[C:9]([C:10]2[CH:11]=[CH:12][CH:13]=[CH:14][CH:15]=2)=[N:8][N:7]=[C:6]2[N:16]([CH2:24][C:25]([N:27]3[CH2:31][CH2:30][CH2:29][CH2:28]3)=[O:26])[N:17]=[C:18]([C:19]([F:22])([F:20])[F:21])[C:5]=12Participants
7
Reactant 4
Product 1
Reagents, catalysts & solvents 2
Procedure
Sodium hydride (18 mg, 0.45 mmol) was added to a solution of 4-chloro-5-phenyl-3-(trifluoromethyl)-1H-pyrazolo[3,4-c]pyridazine (115 mg, 0.38 mmol) and 2-chloro-1-pyrrolidin-1-yl-ethanone (81 mg, 0.55 mmol) in dry DMF (1.5 ml) and the reaction stirred for 21 h. Water and CH2Cl2 where added and the aqueous phase was extracted with CH2Cl2. The organic phases where combined, dried over MgSO4, filtered and evaporated. The residue was purified by column chromatography (silica gel, ethyl acetate/isohexane 2:8 to 1:0) followed by preparative HPLC yielding Compound Iaa as a white solid (23 mg).
Workup
- extractionthe aqueous phase was extracted with CH2Cl2
- dry with materialdried over MgSO4
- filtrationfiltered
- customevaporated
- customThe residue was purified by column chromatography (silica gel, ethyl acetate/isohexane 2:8 to 1:0)
Sources & evidence
- ORD record
- ord-bb455252fea34fda80cd8a3a506dd730
- Source dataset
- uspto-grants-2016_01
- Patent number
- US09227976B2
Reaction notes
Loading…